Key result
Overweight and obesity linked to paradoxical survival advantage over leaner patients with CHF and COPD.
Why the study?
Reports have emerged that obesity positively impacts the prognosis of patients with chronic illnesses such as CHF and COPD, a phenomenon known as the Obesity Paradox, which this article attempts to explain and summarize.
Does obesity improve prognosis and reduce mortality in patients with chronic heart failure and chronic obstructive pulmonary disease?
Does obesity improve prognosis and reduce mortality in patients with chronic heart failure and chronic obstructive pulmonary disease?
The obesity paradox in CHF and COPD suggests that overweight and obese patients may have lower mortality, though this benefit appears largely dependent on maintaining cardiorespiratory fitness and lean muscle mass.
Should not yet change weight targets in CHF-COPD; confirms paradox but leaves causality and fitness role open.
Obesity in recent years has become an epidemic. A high body mass index (BMI) is one of today's most crucial population health indicators. BMI does not directly quantify body fat but correlates well with easier body fat measurements. Like smoking, obesity impacts multiple organ systems and is a major modifiable risk factor for countless diseases. Despite this, reports have emerged that obesity positively impacts the prognosis of patients with chronic illnesses such as chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD), a phenomenon known as the Obesity Paradox. This article attempts to explain and summarize this phenomenon. As it stands, two theories explain this paradox. The muscle mass hypothesis states that obese patients are better adapted to tide through acute exacerbations due to increased reserve because of greater muscle mass. The other theory focuses on brown adipose tissue and its anti-inflammatory effects on the body. We performed a literature review on research articles published in English from 1983 to the present in the following databases - PubMed, Elsevier, and Google Scholar. The following search strings and Medical Subject Headings (MeSH) terms were used: "Obesity," "Heart Failure," "COPD," and "Cardio-Respiratory Fitness." In this review, we looked at the obesity paradox in Heart Failure and COPD. We summarized the current literature on the Obesity Paradox and reviewed its relationship with Cardio-Respiratory Fitness.
No takes yet. Share an insight, caveat, or question.
Ravindran et al. (2022) conducted a review in Chronic Heart Failure (CHF) and Chronic Obstructive Pulmonary Disease (COPD). Obesity / High Body Mass Index (BMI) vs. Normal or low Body Mass Index (BMI) was evaluated. Overweight and obese patients with chronic heart failure and chronic obstructive pulmonary disease demonstrate a paradoxical survival advantage and better prognosis compared to leaner patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: